UK science is having a party. In the last weeks of its term of office the government has made a series of announcements in big ticket science and innovation.
Tailoring the treatment to patients is a grand idea. But there are many obstacles. Science|Business organised a roundtable to debate what could be done.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.